A modeling study on HCC surveillance has highlighted a preference for blood‐based tests over ultrasound plus AFP due to increased convenience and shorter time commitment required.[27] Moreover, the economic feasibility of our assay is a critical aspect, addressing a significant gap in the current landscape of plasma‐based detection approaches. This evidence concerns the gene AFP and hepatocellular carcinoma.